Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and
joint restoration products for hip, knee, shoulder and spine, announced
today revenue of $57.9 million for the third quarter of 2014, a 4%
increase over $55.7 million in the third quarter of 2013.
NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science
tools for translational research and molecular diagnostic products,
today announced that the Journal of Clinical Oncology published
an analysis of data in over 2,100 patients showing that the
risk-of-recurrence (ROR) score generated by the PAM50-based Prosigna™
Breast Cancer Assay predicts the risk of late distant recurrence, after
five years of endocrine therapy, in postmenopausal women with Hormone
Receptor-Positive (HR+) early-stage breast cancer.
Sign-up for NanoString Announces Publication in the Journal of Clinical Oncology Showing the Prosigna Assay Identifies Women With a Low Risk of Late Distant Recurrence of Breast Cancer investment picks
Executive Snapshot: Continued strong financial results:
Year-to-Date 2014 compared to the same period in 2013:
Net income up 14.9%
Diluted EPS up 14.2%
Return on average assets (ROA) rose 9 basis points to 0.98%
Return on average equity (ROE) rose 90 basis points to 11.84%
Improvement in the efficiency ratio from 52.99% in 2013 to 52.35% in 2014
Third quarter 2014 compared to third quarter 2013:
Net income up 4.5%
Diluted EPS up 3.7%
Return on average assets (ROA) up an additional basis point to 0.92% Asset quality improvement:
Virtually every measure of asset quality improved during the third quarter
Nonperforming assets (NPAs) fell $8.0 million or 16% to $43.6 million at September 30, 2014 compared to $51.6 million at September 30, 2013
NPAs to total assets improved from 1.16% to 0.95% over
By David Benoit and Juliet Chung
Activist investor Dan Loeb revealed his Third Point LLC has built a stake in biotechnology company Amgen Inc. and is calling on the company to explore breaking into two separate businesses, according to a letter he sent to Third Point's investors, a common refrain among activists lately.
Unitil Corporation (NYSE:UTL) ( www.unitil.com )
today announced that its Board of Directors declared the regular
quarterly dividend on the Company's common stock of $0.345 per share,
payable on November 28, 2014 to shareholders of record on November 14,
By Russ Britt, MarketWatch
The salvoes that are being fired by Valeant Pharmaceuticals Inc. and Allergan Inc. in their takeover battle have come fast and furious, but one of the shots this week took an unexpected turn.
By Wallace Witkowski and Sue Chang, MarketWatch
SAN FRANCISCO (MarketWatch) -- Shares of Yahoo Inc. and VMware Inc. will be among the many in focus in the extended session Tuesday as companies release quarterly earnings results.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.